<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36362259</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>21</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>03</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Robust Generation of Ready-to-Use Cryopreserved Motor Neurons from Human Pluripotent Stem Cells for Disease Modeling.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13462</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232113462</ELocationID><Abstract><AbstractText>Human pluripotent stem cell (hPSC)-derived motor neurons (MNs) act as models for motor neuron diseases (MNDs), such as amyotrophic lateral sclerosis (ALS) or spinal muscular atrophy. However, the MN differentiation efficiency and viability following cryopreservation require further development for application in large-scale studies and drug screening. Here, we developed a robust protocol to convert hPSCs into MN cryopreservation stocks (hPSCs were converted into &gt;92% motor neural progenitors and &gt;91% MNs). Near-mature MNs were cryopreserved at a high thawing survival rate and 89% MN marker expression on day 32. Moreover, these MNs exhibited classical electrophysiological properties and neuromuscular junction (NMJ) formation ability within only 4&#x2212;6 days after thawing. To apply this platform as an MND model, MN stocks were generated from SOD1G85R, SOD1G85G isogenic control, and sporadic ALS hPSC lines. The thawed ALS MNs expressed ALS-specific cytopathies, including SOD1 protein aggregation and TDP-43 redistribution. Thus, a stable and robust protocol was developed to generate ready-to-use cryopreserved MNs without further neuronal maturation processes for application in MND mechanistic studies, NMJ model establishment, and large-scale drug screening.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ting</LastName><ForeName>Hsiao-Chien</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Hong-Lin</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mei-Fang</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Medical Research, Hualien Tzu Chi Hospital, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harn</LastName><ForeName>Horng-Jyh</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Hualien Tzu Chi Hospital and Tzu Chi University, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shinn-Zong</ForeName><Initials>SZ</Initials><Identifier Source="ORCID">0000-0002-4601-9933</Identifier><AffiliationInfo><Affiliation>Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Hualien Tzu Chi Hospital, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiou</LastName><ForeName>Tzyy-Wen</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Life Science and Graduate Institute of Biotechnology, National Dong Hwa University, Hualien 974, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chia-Yu</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-3585-5944</Identifier><AffiliationInfo><Affiliation>Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, Hualien Tzu Chi Hospital, Hualien 970, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Hualien Tzu Chi Hospital, Hualien 970, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing, Tzu Chi University of Science and Technology, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IMAR-110-01-02</GrantID><Agency>Hualien Tzu Chi Medical Center</Agency><Country/></Grant><Grant><GrantID>MOST 107-2314-B-303-001-, MOST 108-2314-B-303-009-, MOST 109-2314-B-303-023-, MOST 110-2314-B-303-025- and MOST 111-2314-B-303 -027-MY2</GrantID><Agency>National Science and Technology Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039904" MajorTopicYN="Y">Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015925" MajorTopicYN="N">Cryopreservation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cryopreservation</Keyword><Keyword MajorTopicYN="N">disease modeling</Keyword><Keyword MajorTopicYN="N">drug screening</Keyword><Keyword MajorTopicYN="N">electrophysiology</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">neuromuscular junction</Keyword><Keyword MajorTopicYN="N">pluripotent stem cell</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36362259</ArticleId><ArticleId IdType="pmc">PMC9657726</ArticleId><ArticleId IdType="doi">10.3390/ijms232113462</ArticleId><ArticleId IdType="pii">ijms232113462</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal M.K. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med. Res. Rev. 2019;39:733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin. Pharmacother. 2017;18:735&#x2013;738. doi: 10.1080/14656566.2017.1319937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2017.1319937</ArticleId><ArticleId IdType="pubmed">28406335</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R., Pioro E., Myers K., Sirdofsky M., Goslin K., Meekins G., Yu H., Wymer J., Cudkowicz M., Macklin E.A., et al. Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial. Neurotherapeutics. 2017;14:762&#x2013;772. doi: 10.1007/s13311-016-0508-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0508-5</ArticleId><ArticleId IdType="pmc">PMC5509619</ArticleId><ArticleId IdType="pubmed">28070747</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.Y., Ting H.C., Liu C.A., Su H.L., Chiou T.W., Harn H.J., Lin S.Z. Induced Pluripotent Stem Cells: A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery. Cell Transplant. 2018;27:1588&#x2013;1602. doi: 10.1177/0963689718775406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718775406</ArticleId><ArticleId IdType="pmc">PMC6299199</ArticleId><ArticleId IdType="pubmed">29890847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Qian K., Du Z., Cao J., Petersen A., Liu H., Blackbourn L.W.t., Huang C.L., Errigo A., Yin Y., et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell. 2014;14:796&#x2013;809. doi: 10.1016/j.stem.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.02.004</ArticleId><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N., Kitaoka S., Tsukita K., Naitoh M., Takahashi K., Yamamoto T., Adachi F., Kondo T., Okita K., Asaka I., et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012;4:145ra104. doi: 10.1126/scitranslmed.3004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004052</ArticleId><ArticleId IdType="pubmed">22855461</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R., Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K., Izumi Y., Watanabe A., Tsukita K., Woltjen K., Yamamoto T., Hotta A., Kondo T., Kitaoka S., Ohta A., et al. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:eaaf3962. doi: 10.1126/scitranslmed.aaf3962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf3962</ArticleId><ArticleId IdType="pubmed">28539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009;27:275&#x2013;280. doi: 10.1038/nbt.1529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1529</ArticleId><ArticleId IdType="pmc">PMC2756723</ArticleId><ArticleId IdType="pubmed">19252484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S.C., Wernig M., Duncan I.D., Brustle O., Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 2001;19:1129&#x2013;1133. doi: 10.1038/nbt1201-1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1201-1129</ArticleId><ArticleId IdType="pubmed">11731781</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K., Kamiya D., Nishiyama A., Katayama T., Nozaki S., Kawasaki H., Watanabe Y., Mizuseki K., Sasai Y. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 2005;8:288&#x2013;296. doi: 10.1038/nn1402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1402</ArticleId><ArticleId IdType="pubmed">15696161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.Y., Ting H.C., Liu C.A., Su H.L., Chiou T.W., Harn H.J., Lin S.Z., Ho T.J. Differentiation of Human Pluripotent Stem Cells into Specific Neural Lineages. Cell Transplant. 2021;30:9636897211017829. doi: 10.1177/09636897211017829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09636897211017829</ArticleId><ArticleId IdType="pmc">PMC8529300</ArticleId><ArticleId IdType="pubmed">34665040</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.J., Zhang X., Johnson M.A., Wang Z.B., Lavaute T., Zhang S.C. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development. 2009;136:4055&#x2013;4063. doi: 10.1242/dev.036624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.036624</ArticleId><ArticleId IdType="pmc">PMC2778748</ArticleId><ArticleId IdType="pubmed">19906872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B.Y., Zhang S.C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc. 2009;4:1295&#x2013;1304. doi: 10.1038/nprot.2009.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.127</ArticleId><ArticleId IdType="pmc">PMC2789120</ArticleId><ArticleId IdType="pubmed">19696748</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghese L., Dolezalova D., Opitz T., Haupt S., Leinhaas A., Steinfarz B., Koch P., Edenhofer F., Hampl A., Brustle O. Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo. Stem Cells. 2010;28:955&#x2013;964. doi: 10.1002/stem.408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.408</ArticleId><ArticleId IdType="pubmed">20235098</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers S.M., Qi Y., Mica Y., Lee G., Zhang X.J., Niu L., Bilsland J., Cao L., Stevens E., Whiting P., et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol. 2012;30:715&#x2013;720. doi: 10.1038/nbt.2249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2249</ArticleId><ArticleId IdType="pmc">PMC3516136</ArticleId><ArticleId IdType="pubmed">22750882</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiramatsu S., Morizane A., Kikuchi T., Doi D., Yoshida K., Takahashi J. Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application. J. Park. Dis. 2022;12:871&#x2013;884. doi: 10.3233/JPD-212934.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-212934</ArticleId><ArticleId IdType="pmc">PMC9108593</ArticleId><ArticleId IdType="pubmed">34958047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.W., Piao J., Koo S.Y., Kriks S., Chung S.Y., Betel D., Socci N.D., Choi S.J., Zabierowski S., Dubose B.N., et al. Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use. Cell Stem Cell. 2021;28:343&#x2013;355.e5. doi: 10.1016/j.stem.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC8006469</ArticleId><ArticleId IdType="pubmed">33545081</ArticleId></ArticleIdList></Reference><Reference><Citation>Piao J., Zabierowski S., Dubose B.N., Hill E.J., Navare M., Claros N., Rosen S., Ramnarine K., Horn C., Fredrickson C., et al. Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01. Cell Stem Cell. 2021;28:217&#x2013;229.e7. doi: 10.1016/j.stem.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7903922</ArticleId><ArticleId IdType="pubmed">33545080</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani P., Escalante-Chong R., Shelley B.C., Patel-Murray N.L., Xin X., Adam M., Mandefro B., Sareen D., Svendsen C.N., Fraenkel E. Cell freezing protocol suitable for ATAC-Seq on motor neurons derived from human induced pluripotent stem cells. Sci. Rep. 2016;6:25474. doi: 10.1038/srep25474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25474</ArticleId><ArticleId IdType="pmc">PMC4857123</ArticleId><ArticleId IdType="pubmed">27146274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.M., Lee M.S., Chang C.Y., Lin S.Z., Cheng E.H., Liu Y.H., Pan H.C., Lee H.C., Su H.L. Prerequisite OCT4 Maintenance Potentiates the Neural Induction of Differentiating Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Cell Transplant. 2015;24:829&#x2013;844. doi: 10.3727/096368913X675179.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368913X675179</ArticleId><ArticleId IdType="pubmed">24256943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.Y., Chen S.M., Lu H.E., Lai S.M., Lai P.S., Shen P.W., Chen P.Y., Shen C.I., Harn H.J., Lin S.Z., et al. N-butylidenephthalide attenuates Alzheimer&#x2019;s disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons. Sci. Rep. 2015;5:8744. doi: 10.1038/srep08744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08744</ArticleId><ArticleId IdType="pmc">PMC4348654</ArticleId><ArticleId IdType="pubmed">25735452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting H.C., Yang H.I., Harn H.J., Chiu I.M., Su H.L., Li X., Chen M.F., Ho T.J., Liu C.A., Tsai Y.J., et al. Coactivation of GSK3beta and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons. Cells. 2021;10:2773. doi: 10.3390/cells10102773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10102773</ArticleId><ArticleId IdType="pmc">PMC8535155</ArticleId><ArticleId IdType="pubmed">34685754</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z.W., Chen H., Liu H., Lu J., Qian K., Huang C.L., Zhong X., Fan F., Zhang S.C. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 2015;6:6626. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.K., Pfaff S.L. Transcriptional networks regulating neuronal identity in the developing spinal cord. Nat. Neurosci. 2001;4:1183&#x2013;1191. doi: 10.1038/nn750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn750</ArticleId><ArticleId IdType="pubmed">11687828</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y., Come J., Piskorowski R.A., Salah-Mohellibi N., Chevaleyre V., Peschanski M., Martinat C., Nedelec S. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 2015;33:89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Lei Q., Oosterveen T., Ericson J., Matise M.P. Tcf/Lef repressors differentially regulate Shh-Gli target gene activation thresholds to generate progenitor patterning in the developing CNS. Development. 2011;138:3711&#x2013;3721. doi: 10.1242/dev.068270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.068270</ArticleId><ArticleId IdType="pmc">PMC3152926</ArticleId><ArticleId IdType="pubmed">21775418</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.J., Du Z.W., Zarnowska E.D., Pankratz M., Hansen L.O., Pearce R.A., Zhang S.C. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 2005;23:215&#x2013;221. doi: 10.1038/nbt1063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1063</ArticleId><ArticleId IdType="pubmed">15685164</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145&#x2013;1147. doi: 10.1126/science.282.5391.1145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.282.5391.1145</ArticleId><ArticleId IdType="pubmed">9804556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng E.H., Chen W., Chang S.Y., Huang J.J., Huang C.C., Huang L.S., Liu C.H., Lee M.S. Blastocoel volume is related to successful establishment of human embryonic stem cell lines. Reprod. Biomed. Online. 2008;17:436&#x2013;444. doi: 10.1016/S1472-6483(10)60229-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1472-6483(10)60229-5</ArticleId><ArticleId IdType="pubmed">18765016</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Loeffler J.P. Neuromuscular junction destruction during amyotrophic lateral sclerosis: Insights from transgenic models. Curr. Opin. Pharmacol. 2009;9:341&#x2013;346. doi: 10.1016/j.coph.2009.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2009.03.007</ArticleId><ArticleId IdType="pubmed">19386549</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M., Melamed E., Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J. Mol. Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 1977;270:725&#x2013;727. doi: 10.1038/270725a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/270725a0</ArticleId><ArticleId IdType="pubmed">563524</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulle C., Benoit P., Pinset C., Roa M., Changeux J.P. Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. Proc. Natl. Acad. Sci. USA. 1988;85:5728&#x2013;5732. doi: 10.1073/pnas.85.15.5728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.15.5728</ArticleId><ArticleId IdType="pmc">PMC281834</ArticleId><ArticleId IdType="pubmed">2456580</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk T.R., Rousseaux M.W.C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 2020;15:45. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns N.J., Neumann M., Bigio E.H., Holm I.E., Troost D., Hatanpaa K.J., Foong C., White C.L., 3rd, Schneider J.A., Kretzschmar H.A., et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 2007;171:227&#x2013;240. doi: 10.2353/ajpath.2007.070182.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.070182</ArticleId><ArticleId IdType="pmc">PMC1941578</ArticleId><ArticleId IdType="pubmed">17591968</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon G.S., Shim Y.M., Lee D.Y., Kim J.S., Kang M., Ahn S.H., Shin J.Y., Geum D., Hong Y.H., Sung J.J. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations. Mol. Neurobiol. 2019;56:2007&#x2013;2021. doi: 10.1007/s12035-018-1218-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1218-2</ArticleId><ArticleId IdType="pmc">PMC6394608</ArticleId><ArticleId IdType="pubmed">29982983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare B., Lehmann M., Beaudin M., Nordstrom U., Saikali S., Julien J.P., Gilthorpe J.D., Marklund S.L., Cashman N.R., Andersen P.M., et al. Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Macarthur C.C., Fontes A., Ravinder N., Kuninger D., Kaur J., Bailey M., Taliana A., Vemuri M.C., Lieu P.T. Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int. 2012;2012:564612. doi: 10.1155/2012/564612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/564612</ArticleId><ArticleId IdType="pmc">PMC3328201</ArticleId><ArticleId IdType="pubmed">22550511</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>